Open original FDA record ↗Recall record
- FDA identifier
- Z-0749-2016
- Company in FDA record
- bioMerieux, Inc.
- FDA record creation date
- Feb 4, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Bottles may have been exposed to non-normal shipping conditions which may lead to media degradation and impact growth performance.
Source facts
- Action
- Biomerieux sent a Product Recall Notice letter to affected customers. The letter identified the affected product, problem and actions to be taken. Customers were instructed to discontinue use of the referenced part and lot number and discard remaining inventory according to their facility's procedure for culture media. Customers were also instructed to contact their local bioMrieux representative for product replacement.
- Initiated
- 2015-12-24
- Root cause
- Packaging process control
- Terminated
- 2017-12-04
- Distribution
- Distributed in the countries of Angola, Austria, Bosnia, Bulgaria, Cameroon, Czech Republic, Democratic Republic of Congo, France, Germany, Greece, Hungary, Italy, Kazakhstan, Kingdom of Saudi Arabia, Kosovo, Lebanon, Netherlands, Niger, Pakistan, Poland, Republic of Belarus, Romania, Russia, Serbia, Sri Lanka, Spain, Sweden, Switzerland, United Arab Emirates, Turkey and Zimbabwe.
- Recall number
- Z-0749-2016
- Recall status
- Terminated
- CDRH record ID
- 142816
- FDA record created
- 2016-02-04
- Recall event number
- 73027